Inventor · disambiguated record
Danxi Li
Also filed as: LI DANXI
12 granted patents·35 pending applications·134 citations·filing 2001–2024
91Inventor score
Top patents by PatentIndex Score
47 records- 0194US9221917B2Dual variable region antibody-like binding proteins having cross-over binding region orientationBAURIN NICOLAS·Filed 2013·Granted Dec 29, 2015·23 cites·21 claims
- 0294US9181349B2Dual variable region antibody-like binding proteins having cross-over binding region orientationBAURIN NICOLAS·Filed 2013·Granted Nov 10, 2015·29 cites·26 claims
- 0394US8388965B2Antibodies that bind IL-4 and/or IL-13 and their usesRAO ERCOLE·Filed 2008·Granted Mar 5, 2013·56 cites·21 claims
- 0493US11453727B2Antibodies that bind IL-4 and/or IL-13 and their usesSANOFI SA·Filed 2020·Granted Sep 27, 2022·2 cites·12 claims
- 0593US9738728B2Antibodies that bind IL-4 and/or IL-13 and their usesSANOFI SA·Filed 2013·Granted Aug 22, 2017·11 cites·26 claims
- 0692US9732162B2Antibodies that bind IL-4 and/or IL-13 and their usesSANOFI SA·Filed 2013·Granted Aug 15, 2017·8 cites·37 claims
- 0791US2025313651A1Antibodies that bind il-4 and/or il-13 and their usesSANOFI SA·Filed 2024·Application pending·0 cites
- 0886US10759871B2Antibodies that bind IL-4 and/or IL-13 and their usesSANOFI SA·Filed 2017·Granted Sep 1, 2020·1 cites·6 claims
- 0982US2023235088A1Antibodies that bind il-4 and/or il-13 and their usesSANOFI SA·Filed 2022·Application pending·0 cites
- 1073US2021189011A1Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region OrientationSANOFI SA·Filed 2020·Application pending·0 cites
- 1169US11008389B2Uses of a dual V region antibody-like proteinSANOFI SA·Filed 2016·Granted May 18, 2021·1 cites·11 claims
- 1268US2008166709A1MARKs as Modifiers of the p53 Pathway and Methods of UseEXELIXIS INC·Filed 2007·Application pending·0 cites
- 1366US2008241131A1SPHKS as modifiers of the p53 pathway and methods of useEXELIXIS INC·Filed 2008·Application pending·0 cites
- 1465US2018155450A1Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region OrientationSANOFI SA·Filed 2017·Application pending·0 cites
- 1564US6924117B2Human RRP sequences and methods of useEXELIXIS INC·Filed 2001·Granted Aug 2, 2005·2 cites·5 claims
- 1661US2021221882A1Uses of a dual v region antibody-like proteinSANOFI SA·Filed 2021·Application pending·0 cites
- 1760US2016200811A1Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region OrientationSANOFI SA·Filed 2015·Application pending·0 cites
- 1860US2012251541A1Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region OrientationBAURIN NICOLAS·Filed 2012·Application pending·0 cites
- 1959US2013209469A1Antibodies that bind il-4 and/or il-13 and their usesRAO ERCOLE·Filed 2013·Application pending·0 cites
- 2059US2010275275A1HADHs as Modifiers of the p21 Pathway and Methods of UseEXELIXIS INC·Filed 2009·Application pending·0 cites
- 2154US2006160764A1LIMKs as modifiers of p53 pathway and methods of useEXELIXIS INC·Filed 2006·Application pending·0 cites
- 2253US7049088B2PRMTs as modifiers of the p53 pathway and methods of useEXELIXIS INC·Filed 2002·Granted May 23, 2006·1 cites·2 claims
- 2352US8153384B2Marks as modifiers of the p53 pathway and methods of useFRIEDMAN LORI·Filed 2010·Granted Apr 10, 2012·0 cites·15 claims
- 2451US2005181481A1HADHs as modifiers of the p21 pathway and methods of useEXELIXIS INC·Filed 2005·Application pending·0 cites
- 2551US2005227228A1Map3ks as modifiers of the p53 pathway and methods of useFRIEDMAN LORI·Filed 2002·Application pending·0 cites
- 2651US2005186200A1HADHs as modifiers of the p21 pathway and methods of useEXELIXIS INC·Filed 2005·Application pending·0 cites
- 2750US2003087266A1IGs as modifiers of the p53 pathway and methods of useFiled 2002·Application pending·0 cites
- 2850US2011159508A1GFATS as Modifiers of the P53 Pathway and Methods of UseEXELIXIS INC·Filed 2010·Application pending·0 cites
- 2948US2003027230A1HPRP4s as modifiers of the p53 pathway and methods of useFiled 2002·Application pending·0 cites
- 3047US6927022B2HADHs as modifiers of the p21 pathway and methods of useEXELIXIS INC·Filed 2002·Granted Aug 9, 2005·0 cites·21 claims
- 3147US2005112568A1Dgks as modifiers of the p53 pathwha and methods of useFiled 2002·Application pending·0 cites
- 3247US2003013144A1HS2STs as modifiers of the p53 pathway and methods of useFiled 2002·Application pending·0 cites
- 3347US2005170344A1Chds as modifiers of the p53 pathway and methods of useFiled 2002·Application pending·0 cites
- 3447US2003165809A1MARKs as modifiers of the p53 pathway and methods of useFiled 2002·Application pending·0 cites
- 3547US2002192695A1PIBs as modifiers of the p53 pathway and methods of useFiled 2002·Application pending·0 cites
- 3647US2003027188A1SLC7s as modifiers of the p53 pathway and methods of useFiled 2002·Application pending·0 cites
- 3747US2003036076A1CADs as modifiers of the p53 pathway and methods of useFiled 2002·Application pending·0 cites
- 3846US2006121457A1Gfats as modifiers of the p53 pathway and methods of useEXELIXIS INC·Filed 2002·Application pending·0 cites
- 3943US2013344074A1Uses of a dual v region antibody-like proteinBENDER FLORENT·Filed 2012·Application pending·0 cites
- 4041US2003036078A1P5CRs as modifiers of the p53 pathway and methods of useFiled 2002·Application pending·0 cites
- 4141US2007134732A1Lces as modifiers of the p53 pathway and methods of useEXELIXIS INC·Filed 2002·Application pending·0 cites
- 4241US2003138431A1LRRCAPs as modifiers of the p53 pathway and methods of useFiled 2002·Application pending·0 cites
- 4340US2006252035A1Sphks as modifiers of the p53 pathway and methods of useFRIEDMAN LORI·Filed 2002·Application pending·0 cites
- 4439US2003022209A1ADSLs as modifiers of the p53 pathway and methods of useFiled 2002·Application pending·0 cites
- 4537US2006024673A1Slc2as as modifiers of the p53 pathway and methods of useFRIEDMAN LORI·Filed 2002·Application pending·0 cites
- 4636US2006024665A1PRMTs as modifiers of the p53 pathway and methods of useFRIEDMAN LORI·Filed 2005·Application pending·0 cites
- 4734US2006121041A1Gpcs as modifiers of the irrtk p21 pathways and methods of useFRIEDMAN LORI·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Danxi Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →